Clinical and economic analysis of the medicinal nomenclature for preferential categories of citizens

Written by Maneeva E.S., Eliseeva E.V.

  UDK: 615:338.46 | Pages: 84–87 | Full text PDF | Open PDF 


Objective. In the article we presented the dates of Clinical and Economic Analysis of the medicinal nomenclature for preferential categories of citizens who need of social support.
Methods. The aim of our study is to analyse the rationality of medicinal structure and to compare it with The List of Vital and Necessary Medicines of Russian Federation. We studied the structure of medicinal purchases with the help of ABC VEN-analysis. We accentuated VEN-analysis that evaluated expenses for significant medicines.
Results. The study has demonstrated that 112 from 150 medicines (74,7 %) were attributed to class V (vital medicines) by VEN-analysis, 25 from 150 medicines (16,7 %) were attributed to class E (essential medicines) and only 13 from 150 medicines (8,6 %) were attributed to class N (non-essential medicines). In the analysis of the range of medicinal nomenclature for compliance with the List of Vital and Essential Medicines in accordance with Annex № 2 to the Order of the Government of the Russian Federation dated 30 December 2014 No. 2782-r found that savings, which in itself carries the adoption of the order of 1,676,811.40 rubles by reducing the number of medicines with low or unproven therapeutic efficacy.
Conclusions. According to our research the medicinal nomenclature was rational. The feasibility of utilization of financial resources and the priority of vital medicines is dictated by the principles of evidence-based medicine, contributing to a rational choice of medicines in each clinical case. Accepted Government Decree № 2782-r will in the future save money by avoiding medicines with unproven efficacy and direct means for highly efficient and safe medicines.

Links to authors:

E.S. Maneeva, E.V. Eliseeva
Pacific State Medical University (2 Ostryakova Ave. Vladivostok 690950 Russian Federation)

1. Vorobev P.A. Modeling in the clinical and economic analysis // Glavvrach. 2005. No. 11. P. 38–45.
2. Eliseeva E.V. Rational use of drugs: guidelines for physicians. Vladivostok: Meditsina DV, 2010. 70 p.
3. Eliseeva E.V., Kropotov A.V., Dyuyzen I.V. Clinical pharmacology of neurotropic drugs: textbook. Vladivostok: Meditsina DV, 2015. 152 p.
4. Eliseeva E.V., Khotimchenko Yu.S., Kropotov A.V. 15 years of clinical pharmacology in Primorsky territory // Pacific Medical Journal. 2013. No. 2. P. 5–8.
5. Eliseeva E.V., Shmykova I.I., Gaynullina Yu.I. [et al.]. Service of clinical pharmacology as a guarantor of the efficient and safe use of medicines // Pacific Medical Journal. 2008. No. 3. P. 92–94.
6. Eliseeva E.V., Shmykova I.I., Sedykh T.N. [et al.]. Postgraduate stage training of doctors at the Department of Clinical Pharmacology of VSMU: organizational, methodological and clinical aspects // Pacific Medical Journal. 2007. No. 2. P. 70–72.
7. Zagorodnikova K.A. Monitoring the safety of medicines in the world – methodological approaches // Pacific Medical Journal. 2015. No. 2. P. 11–15.
8. Maksimova T.M., Lushkina N.P., Alekseeva N.Yu. [et al.]. Evaluation of drug therapy in the treatment of hypertension in a hospital // Problems of Social Hygiene, Public Health and History of Medicine. 2015. No. 1. P. 14–18.
9. Rostova N.B., Kudryashova A.I. WHO advice for the rational drug use // Problems of Social Hygiene, Public Health and History of Medicine. 2015. No. 3. P. 29–32.
10. Solodovnikov V.V., Gaynullina Yu.I., Eliseeva E.V., Preobrazhenskaya O.V. Reimbursement program: guidelines for physicians. Vladivostok: Meditsina DV, 2007. 107 p.
11. Drug handbook of the Formulary committee. URL: http://rspor. ru/index.php?mod1=preparats&mod2=db2&cmd=list&simb ol= %C0 (date of access: 02.18.2016).
12. Frolov M.Yu., Barkanova O.N., Shatalova O.V. The methodology of the ABC VEN-analysis // Lekarstvenyi vestnik. 2012. No. 6. P. 3–6.
13. Yakusheva E.N. Optimization of selection of drugs in the formulary lists on the basis of harmonization of regulations, clinical and pharmacological and pharmacoeconomic analysis: thesis abstract, MD. Smolensk, 2009. 48 p.
14. Ziganshina L.E., Abakumova T. Cerebrolysin for acute ischaemic stroke // Cochrane Database Systematic Review. 2015. URL: www.ncbi.nlm.nih.gov/pubmed/26083192 (дата обращения:
15. Soleymani F., Abdollahi M. Management information system in promoting rational drug use // International Journal of Pharmacology. 2012. Vol. 8, Nо. 6. P. 586–589.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.